Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M. D. Malova"'
Autor:
I. O. Kostareva, K. I. Kirgizov, E. B. Machneva, T. Z. Aliev, Yu. V. Lozovan, K. A. Sergeenko, N. A. Burlaka, T. I. Potemkina, K. V. Mitrakov, A. Yu. Yelfimova, A. S. Slinin, M. D. Malova, R. R. Fatkhullin, N. G. Stepanyan, N. A. Batmanova, T. T. Valiev, S. R. Varfolomeeva
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:16-23
Currently, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment option for relapsed / refractory (R / R) acute leukemia (AL) and high-risk AL. In this article, we present our own experience of allo-HSCT in children
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9454a03de0d8919676eb981de4a7c289
https://doi.org/10.24287/1726-1708-2023-22-2-16-23
https://doi.org/10.24287/1726-1708-2023-22-2-16-23
Autor:
K. A. Sergeenko, T. Z. Aliev, I. O. Kostareva, Yu. V. Lozovan, M. D. Malova, N. A. Batmanova, T. T. Valiev, E. B. Machneva, K. I. Kirgizov
Publikováno v:
Russian Journal of Pediatric Hematology and Oncology. 9:85-92
Despite improved understanding of the biology of the disease and the use of multicomponent chemotherapy, the prognosis for children with relapsed or refractory B-line acute lymphoblastic leukemia (B-ALL) remains poor. Currently, the only definitive t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51d1c6d25207b39b43e9e37f1a64e30a
https://doi.org/10.21682/2311-1267-2022-9-2-85-92
https://doi.org/10.21682/2311-1267-2022-9-2-85-92